Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype

Mushtaq, N., Redpath, M.B., Luzio, J.P. and Taylor, P.W. (2004) Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype. Antimicrobial Agents and Chemotherapy, 48 (5). pp. 1503-1508. 10.1128/AAC.48.5.1503-1508.2004.

Full text available as:

[img]
Preview
PDF
122Kb

DOI: 10.1128/AAC.48.5.1503-1508.2004

Abstract

Escherichia coli is a common cause of meningitis and sepsis in the newborn infant, and the large majority of isolates from these infections produce a polysialic acid (PSA) capsular polysaccharide, the K1 antigen, that protects the bacterial cell from immune attack. We determined whether a capsule-depolymerizing enzyme, by removing this protective barrier, could alter the outcome of systemic infection in an animal model. Bacteriophage-derived endosialidase E (endoE) selectively degrades the PSA capsule on the surface of E. coli K1 strains. Intraperitoneal administration of small quantities of recombinant endoE (20 μg) to 3-day-old rats, colonized with a virulent strain of K1, prevented bacteremia and death from systemic infection. The enzyme had no effect on the viability of E. coli strains but sensitized strains expressing PSA to killing by the complement system. This study demonstrates the potential therapeutic efficacy of agents that cure infections by modification of the bacterial phenotype rather than by killing or inhibition of growth of the pathogen.

Item Type:Article
Additional Information:Full text available in print and electronically at the School of Pharmacy Library.
Departments, units and centres:Department of Pharmaceutics > Department of Pharmaceutics
ID Code:602
Journal or Publication Title:Antimicrobial Agents and Chemotherapy
Deposited By:Library Staff
Deposited On:16 Jan 2007
Last Modified:18 Nov 2011 16:41

Repository Staff Only: Item control page

School of Pharmacy Staff Only: Edit a copy to replace this item